Clinical end point acceptance limit [Study As­sess­ment]

posted by PKS – India, 2019-04-05 11:17 (1847 d 06:51 ago) – Posting: # 20128
Views: 3,191

❝ ❝ Should I conclude bio-equivalence with the values of [-0.2025, 0.076] in clinical end point study. Can I assume it as within the interval of (-0.20, 0.20)


❝ What does your protocol say on exactly that matter?


My protocol says within (-0.20 and 0.20)

Complete thread:

UA Flag
Activity
 Admin contact
22,993 posts in 4,828 threads, 1,651 registered users;
99 visitors (1 registered, 98 guests [including 3 identified bots]).
Forum time: 18:09 CEST (Europe/Vienna)

Never never never never use Excel.
Not even for calculation of arithmetic means.    Martin Wolfsegger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5